Cytokines, Stress, and Depression

Conclusions and Perspectives
  • Robert Dantzer
  • Emmanuelle E. Wollman
  • Ljubisa Vitkovic
  • Raz Yirmiya
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 461)


From the data that are reviewed in this volume, several important points emerge: (1) cytokines administered to patients and laboratory animals induce symptoms of depression, including, depressed mood, decreased interest in daily activities, anhedonia, reduced food intake, sleep disorders, hyperactivity of the HPA axis, and glucocorticoid resistance; (2) exposure to stressors can induce the expression of cytokines at the periphery and in the brain, although the exact conditions in which this occurs are still elusive; (3) depressed patients display an activation of the mono-cyte/macrophage arm of the immune response; (4) clinical diseases with an inflammatory component are associated with a high prevalence of depressive disorders; (5) antidepressants have anti-inflammatory properties and attenuate the behavioral effects of immune challenge.


Depressed Patient Quinolinic Acid Inescapable Shock Cytokine Therapy Brain Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bauer, J., Hohagen, F., Gimmel, E., Bruns, F., Lis, S., Krieger, S., Ambach, W., Guthmann, A., Grunze, H., & Fritsch-Montero, R. (1995). Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biological Psychiatry, 38, 611–621.PubMedCrossRefGoogle Scholar
  2. DeSimoni, M. G., Seroni, M., DeLuigi, A., Manfridi, A., Mantovani, A., & Ghezzi, P. (1990). Intracere-broventricular injection of IL-1 induces high circulating levels of IL-6. Journal of Experimental Medicine, 171, 1773–1778.CrossRefGoogle Scholar
  3. DSM-IV, Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition). (1994). Washington, DC: American Psychiatric Association.Google Scholar
  4. Ernst, C. (1997). Epidemiology of depression in late life. Current Opinions in Psychiatry, 10, 107–112.CrossRefGoogle Scholar
  5. Heyes, M. P., Saito, K., Chen, C. Y., Proescholdt, M. G., Nowak, T. S. Jr., Li, J., Beagles, K. E., Proescholdt, M. A., Zito, M. A., Kawai, K., & Markai, S. P. (1997). Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation. Journal of Neurochemistry, 69, 1519–1529.PubMedCrossRefGoogle Scholar
  6. Koslow, S. H., Meinecke, D. L., Lederhendler, I.I., Khachaturian, H., Nakamura, R. K., Karp, D., Vitkovic, L., Glanzman, D. L., & Zalcman, S., Editors (1995). The Neuroscience of Mental Health II, NIH Publication No. 95-4000, Washington, DC: U.S. Government Printing Office.Google Scholar
  7. Krueger, J. M. & Majde, J. (1994). Microbial products and cytokines in sleep and fever regulation. Critical Reviews in Immunology 14, 335–379.Google Scholar
  8. Leonard, B. E. (1987). Stress, the immune system and mental illness. Stress Medicine, 3, 257–258.CrossRefGoogle Scholar
  9. Lopez, J. H., Palkovits M., Arato, M., Mansur A., Akil, H., & Watson, S. J. (1992). Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid mRNA in pituitaries of sicicide victims. Neuroendocrinology 56, 491–501.PubMedGoogle Scholar
  10. Maes, M., Smith, R., & Scharpe, S. (1995). The monocyte-T lymphocyte hypothesis of major depression. Psychoneuroendocrinology, 20, 111–116.PubMedCrossRefGoogle Scholar
  11. Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998). Prevention of allogeneic fetal rejection by tryptophan catabolism. Science, 281, 1191–1193.PubMedCrossRefGoogle Scholar
  12. Sakic, B., Denburg, J. A., Denburg, S. D., & Szechtman, H. (1986). Blunted sensitivity to sucrose in autoimmune MRL-1pr mice: A curve shift study. Brain Research Bulletin, 41, 305–311.Google Scholar
  13. Seligman, S. E. P. (1975). Helplessness San Francisco: Freeman.Google Scholar
  14. Steiner, J.E., Lifschitz, L., & Perl, E. (1993). Taste and odor: reactivity in depressive disorders, a multidisciplinary approach. Perceptual and Motor Skills, 77, 1331–1346.PubMedGoogle Scholar
  15. Swiergel, A. H., Smagin, G. N., Johnson, L. J., & Dunn, A. J. (1997). The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1 receptor antagonist (IL-1ra). Brain Research, IT77, 696–704.Google Scholar
  16. Turnbull, A. V. & Rivier, C. (1996). Cytokine effects on neuroendocrine axes: influence of nitric oxide and carbon monoxide. In N. J. Rothwell(Ed.), Cytokines in the Nervous System (pp. 93–116). Austin: Landes.Google Scholar
  17. Vitkovic, L. & Koslow, S. H., Editors (1994). Neuroimmunologly and Mental Health. NIH Publication No 94-3774, Washington, D.C.: U.S. Government Printing Office.Google Scholar
  18. Walker, L. G., Walker, M. B., Heys, S. D., Lolley, J., Wesnes, K., & Eremin, O. (1997). The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial. Psychooncology, 6, 290–301.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic/Plenum Publishers 1999

Authors and Affiliations

  • Robert Dantzer
  • Emmanuelle E. Wollman
  • Ljubisa Vitkovic
  • Raz Yirmiya

There are no affiliations available

Personalised recommendations